Influenza (quadrivalent) vaccine is under clinical development by Pfizer and cur...
Opzelura is under clinical development by Incyte and currently in Phase II for C...
SCDARIC-33 is under clinical development by Regeneron Pharmaceuticals and curren...
Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelt...
Walden reported positive topline data from a Phase I clinical trial of its lead ...
The two companies will develop neuroplastogens for psychiatric disorders as psyc...
Cytokinetics plans to file for approval in both the US and Europe for its hypert...
Dandelion Health’s database can be used as a tool for sponsors to decide which i...
Sanofi has announced a significant investment exceeding €1bn ($1.07bn) to expand...
The UK Government is set to revise legislation, allowing professionals to supply...
Pint Pharma has announced that COFEPRIS in Mexico has approved ORLADEYO (berotra...
The UK NHS has introduced Pfizer's tafamidis for transthyretin amyloidosis cardi...
The approval was supported by the TRIDENT-1 trial studying Augtyro in TKI-naïve ...
Almost 12 months after the South American Summit, advancing pharma trade and rai...
Shionogi has concluded an exclusive global licence agreement for Maze Therapeuti...
Tabuk obatined rights to commercialise Formosacs l'obetasol propionate ophthalmi...
